Alliqua BioMedical, Inc. is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds. Alliqua is building this portfolio through its proprietary hydrogel technology platform, targeted acquisitions, and through licensing and distribution agreements with strategic partners that include sorbion GmbH & Co. KG and Celgene Cellular Therapeutics, a subsidiary of Celgene Corporation. Alliqua's contract manufacturing business unit provides custom hydrogels to the OEM market. The Company is headquartered in Langhorne, PA.
Type
Public
HQ
Morrisville, US
Employees
87 (est)
Alliqua is headquartered in Morrisville, US

Key People at Alliqua

Phillip Forman

Phillip Forman

Executive VP Clinical Affairs
Steven C. Berger

Steven C. Berger

Chief Financial Officer
Brad C. Barton

Brad C. Barton

COO
David Johnson

David Johnson

CEO, and Member of the Board of Directors

Alliqua Locations

Morrisville, US

Alliqua Metrics

Alliqua Summary

Market capitalization

$17.9 M

Closing share price

$0.59
Alliqua's latest market capitalization is $17.9 M.

Alliqua Market Value History

29% of current employees of Alliqua are female and 71% are male.

Alliqua Online Presence

Alliqua News

Alliqua Company Life

You may also be interested in